Rexulti Drug Interactions
Currently displaying 130 drugs known to have a major interaction with Rexulti (brexpiprazole).
- 130 major drug interactions
- 449 moderate drug interactions
- 1 minor drug interaction
Major interactions with Rexulti (brexpiprazole)
Note: Showing generic names only.
A
B
C
- cabergoline
- carbamazepine
- celecoxib
- ceritinib
- cimetidine
- cinacalcet
- ciprofloxacin
- clarithromycin
- clobazam
- clotrimazole
- clozapine
- cobicistat
- codeine
- conivaptan
- crizotinib
D
- dacomitinib
- darifenacin
- darunavir
- delavirdine
- deutetrabenazine
- dezocine
- diltiazem
- diphenhydramine
- dronedarone
- duloxetine
- duvelisib
E
F
G
H
I
K
L
M
- meperidine
- methadone
- methotrimeprazine
- metoclopramide
- metrizamide
- mibefradil
- mifepristone
- mirabegron
- mitotane
- morphine
- morphine liposomal
N
O
P
- panobinostat
- paroxetine
- pentazocine
- pergolide
- phenobarbital
- phenytoin
- posaconazole
- pramipexole
- primidone
- propoxyphene
Q
R
S
T
- tapentadol
- telaprevir
- telithromycin
- tetrabenazine
- tolcapone
- topiramate
- tramadol
- troleandomycin
- tucatinib
V
Z
Rexulti alcohol/food interactions
There are 4 alcohol/food interactions with Rexulti (brexpiprazole).
Rexulti disease interactions
There are 14 disease interactions with Rexulti (brexpiprazole) which include:
- suicidality
- dementia
- NMS
- aspiration
- seizure
- hematologic abnormalities
- hyperglycemia/diabetes
- hypotension
- lipid alterations
- renal impairment
- weight gain
- hepatic impairment
- hyperprolactinemia
- tardive dyskinesia
More about Rexulti (brexpiprazole)
- Rexulti consumer information
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (451)
- Drug images
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- Generic availability
- Support group
- FDA approval history
- Drug class: atypical antipsychotics
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.